Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Leaf Resources is an Australian industrial biotechnology company focused on the sustainable production of high-value chemicals from plant biomass. The company's proprietary Glycell™ process converts lignocellulosic biomass into industrial sugars and lignin, which serve as renewable building blocks for various applications. Following a strategic pivot and merger with Essential Pine Chemicals, the company has focused on the extraction of natural pine chemicals, including rosin and terpenes, for use in the flavors, fragrances, and industrial markets. Leaf Resources aims to provide sustainable alternatives to petroleum-based products for the global chemical industry. The company operates a production facility in New Zealand and continues to explore licensing opportunities for its core technology platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Leaf Resources.